Prati
Prof. Gheyath K. Nasrallah
Prof. Gheyath K. Nasrallah
Professor of Biomedical Science, College of Health Sciences, QU health, Qatar University
Potvrđena adresa e-pošte na qu.edu.qa - Početna stranica
Naslov
Citirano
Citirano
Godina
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants
LJ Abu-Raddad, H Chemaitelly, AA Butt
New England Journal of Medicine 385 (2), 187-189, 2021
11312021
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 385 (24), e83, 2021
9312021
Potential adverse effects of resveratrol: A literature review
A Shaito, AM Posadino, N Younes, H Hasan, S Halabi, D Alhababi, ...
International journal of molecular sciences 21 (6), 2084, 2020
5622020
Effects of previous infection and vaccination on symptomatic omicron infections
HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ...
New England Journal of Medicine 387 (1), 21-34, 2022
5202022
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ...
Viruses 11 (8), 762, 2019
5202019
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ...
Nature medicine 27 (12), 2136-2143, 2021
4842021
Alternate biobased route to produce δ-Decalactone: Elucidating the role of solvent and hydrogen evolution in catalytic transfer hydrogenation
MI Alam, TS Khan, MA Haider
ACS Sustainable Chemistry & Engineering 7 (3), 2894-2898, 2018
460*2018
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2
N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ...
Viruses 12 (6), 582, 2020
4482020
Protection against the Omicron variant from previous SARS-CoV-2 infection
HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ...
New England Journal of Medicine 386 (13), 1288-1290, 2022
4442022
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar
H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ...
Nature medicine 27 (9), 1614-1621, 2021
4272021
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 386 (19), 1804-1816, 2022
4032022
Epstein–Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update
MK Smatti, DW Al-Sadeq, NH Ali, G Pintus, H Abou-Saleh, GK Nasrallah
Frontiers in oncology 8, 211, 2018
3892018
Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety
A Shaito, DTB Thuan, HT Phu, THD Nguyen, H Hasan, S Halabi, ...
Frontiers in pharmacology 11, 422, 2020
3802020
Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms
H Slika, H Mansour, N Wehbe, SA Nasser, R Iratni, G Nasrallah, A Shaito, ...
Biomedicine & Pharmacotherapy 146, 112442, 2022
2992022
Synthesis, bioapplications, and toxicity evaluation of chitosan-based nanoparticles
BR Rizeq, NN Younes, K Rasool, GK Nasrallah
International journal of molecular sciences 20 (22), 5776, 2019
2862019
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
THG Phan, P Paliogiannis, GK Nasrallah, R Giordo, AH Eid, AG Fois, ...
Cellular and Molecular Life Sciences 78, 2031-2057, 2021
2782021
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar
H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ...
Nature communications 13 (1), 3082, 2022
2412022
Pseudomonas Aeruginosa: Arsenal of Resistance Mechanisms, Decades of Changing Resistance Profiles, and Future Antimicrobial Therapies
ME El Zowalaty, AA Al Thani, TJ Webster, AE El Zowalaty, HP Schweizer, ...
Future Microbiology 10 (10), 1683-1706, 2015
2152015
Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa
AF Majdalawieh, MW Fayyad, GK Nasrallah
Critical reviews in food science and nutrition 57 (18), 3911-3928, 2017
2092017
Severity of SARS-CoV-2 reinfections as compared with primary infections
LJ Abu-Raddad, H Chemaitelly, R Bertollini
New England Journal of Medicine 385 (26), 2487-2489, 2021
1982021
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20